Abstract
Objective
Cancer-related cognitive changes (CRCC) can have a profound impact on a cancer survivor’s quality of life. However, cancer survivors frequently report receiving limited information about their experience of CRCC from their oncology specialists. This qualitative study aimed to explore the perceptions of oncology specialists regarding CRCC and the potential for their views to influence their decisions about patient care.
Methods
Thirteen medical oncologists and five radiation oncologists currently practising in Australia participated in this study. Data collection involved individual semi-structured interviews via telephone. Data were audio-recorded, transcribed verbatim and analysed using a thematic approach.
Results
Four key themes emerged: (1) beliefs about the impact of priming on cancer survivors’ perceived cognitive function, (2) perceptions of who is more likely to raise concerns of cognitive change, (3) uncertainty of how to best manage CRCC, and (4) the perceived role of oncologists in the management of CRCC.
Conclusions
CRCC and its impact on the cancer survivor’s journey have been under-addressed by oncology specialists, and they are uncertain of potential management strategies. With cancer survival rates increasing, there is a need for specific interventions and management guidelines addressing CRCC and their effects on cancer survivors. Future exploration should focus on the survivor as central to their care and holistic approaches to CRCC management involving all members of the multidisciplinary team.
Similar content being viewed by others
References
AIHW & AACR (2012) Cancer in Australia 2012: an overview. AIHW, Canberra
Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 27:2489–2495. doi:10.1200/JCO.2008.20.3232
Mao JJ, Bowman MA, Stricker CT et al (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27:933–938. doi:10.1200/JCO.2008.18.0679
Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK (2007) Views of primary care providers on follow-up care of cancer patients. Fam Med 39:477–482
Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. National Academic Press, Washington DC
Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629. doi:10.1093/annonc/mdm500
Mehnert A, Scherwath A, Schirmer L et al (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108–118. doi:10.1016/j.pec.2006.11.005
Selamat MH, Loh SY, Mackenzie L, Vardy J (2014) Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. Plos Med 9:e108002. doi:10.1371/journal.pone.0108002
Argyriou AA, Assimakopoulos K, Iconomou G, Giannakopoulou F, Kalofonos HP (2011) Either called “Chemobrain” or “Chemofog”, the long-term chemotherapy- induced cognitive decline in cancer survivors is real. J Pain Symptom Manag 41:126–139. doi:10.1016/j.jpainsymman.2010.04.021
McAllister TW, Ahles TA, Saykin AJ et al (2004) Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments. Curr Psychiatry Rep 6:364–371. doi:10.1007/s11920-004-0023-y
Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913. doi:10.1002/cncr.22610
Vardy J, Booth C, Pond GR et al (2007) Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. J Clin Oncol 25:9070
Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi:10.1038/nrc2073
Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647–1656. doi:10.1007/s00520-010-0997-4
Biglia N, Bounous VE, Malabaila A et al (2012) Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care 21:485–492. doi:10.1111/j.1365-2354.2011.01320.x
Mitchell T, Turton P (2011) ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy – a descriptive phenomenological study. Eur J Cancer Care 20:539–548. doi:10.1111/j.1365-2354.2011.01244.x
Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223–232. doi:10.1007/s11764-009-0098-x
Cheung YT, Shwe M, Tan EHJ, Chui WK, Ng R, Chan A (2013) Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia. J Cancer Surviv 7:146–154. doi:10.1007/s11764-012-0256-4
Munir F, Kalawsky K, Lawrence C, Yarker J, Haslam C, Ahmed S (2011) Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis. Cancer Nurs 34:385–392. doi:10.1097/NCC.0b013e31820254f3
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101. doi:10.1191/1478088706qp063oa
Aitken C, Power R, Dwyer R (2008) A very low response rate in an on‐line survey of medical practitioners. Aust NZ J Public Health 32:288–289. doi:10.1111/j.1753-6405.2008.00232.x
Brinkmann S (2013) Qualitative interviewing. Oxford University Press, Oxford
Curtin M, Fossey E (2007) Appraising the trustworthiness of qualitative studies: guidelines for occupational therapists. Aust Occup Ther J 54:88–94. doi:10.1111/j.1440-1630.2007.00661.x
Jiwa M, Packer TL, Merriman G et al (2008) Timely cancer diagnosis and management as a chronic condition: opportunities for primary care. Med J Aust 189:78–82
McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling L, Lorig K, Wagner E (2011) Self-management: enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 61:50–62. doi:10.3322/caac.20093
Phillips JL, Currow DC (2010) Cancer as a chronic disease. Collegian 17:47–50. doi:10.1016/j.colegn.2010.04.007
Epstein R, Street RL (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda
Olver I, Whitford H, Denson L, Peterson M, Olver S (2009) Improving informed consent to chemotherapy: a randomized controlled trial of written information versus an interactive multi-media CD-ROM. Patient Educ Couns 74:197–204. doi:10.1016/j.pec.2008.08.021
Friedman A, Cosby R, Boyko S, Hatton-Bauer J, Turnbull G (2011) Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations. J Cancer Educ 26:12–21. doi:10.1007/s13187-010-0183-x
Schagen SB, Das E, van Dam FS (2009) The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psycho-Oncology 18:674–678. doi:10.1002/pon.1454
Skaali T, Fossa SD, Andersson S et al (2011) Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. J Psychosom Res 70:403–410. doi:10.1016/j.jpsychores.2010.12.004
Duijts SFA, van Egmond MP, Spelten E, van Muijen P, Anema JR, van der Beek AJ (2014) Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psycho-Oncology 23:481–492. doi:10.1002/pon.3467
Bradley CJ, Neumark D, Bednarek HL, Schenk M (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24:137–160. doi:10.1016/j.jhealeco.2004.07.003
Player L, Mackenzie L, Willis K, Loh SY (2014) Women’s experiences of cognitive changes or ‘chemobrain’ following treatment for breast cancer: A role for occupational therapy? Aust Occup Ther J 61:230–240. doi:10.1111/1440-1630.12113
Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39:31–40. doi:10.1188/12.onf.e31-e40
Reid-Arndt SA, Yee A, Perry MC, Hsieh C (2009) Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 27:415–434. doi:10.1080/07347330903183117
Fleissig A, Jenkins V, Catt S, Fallowfield L (2006) Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 7:935–943. doi:10.1016/S1470-2045(06)70940-8
Schuurs A, Green HJ (2013) A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life. Psycho-Oncology 22:1043–1049. doi:10.1002/pon.3102
Newman R, Campbell C (2013) An occupational therapy perspective in addressing breast cancer-related cognitive dysfunction in the survivorship phase. Phys Disabil Spec Interest Section Q Am Occup Ther Assoc 36:1–3
Acknowledgments
The authors thank the participating oncology specialists for sharing their time, thoughts and experiences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval was obtained from the Human Research Ethics Committee at the University of Sydney, Australia (reference no. 2014/323).
Conflict of interest
The authors have no conflict of interest to declare in relation to this study.
Rights and permissions
About this article
Cite this article
Smidt, K., Mackenzie, L., Dhillon, H. et al. The perceptions of Australian oncologists about cognitive changes in cancer survivors. Support Care Cancer 24, 4679–4687 (2016). https://doi.org/10.1007/s00520-016-3315-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3315-y